TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22520142

Group type: EXPERIMENTAL
Intervention: Pentavalent rotavirus vaccine (PRV)
Number of subjects: 5468
Study: 20473067

Group type: EXPERIMENTAL
Intervention: Adjunctive aripiprazole
Number of subjects: 724

Group type: COMPARATOR
Intervention: Antidepressant therapy alone (Control)
Number of subjects: 724
Study: 17912124

Group type: EXPERIMENTAL
Intervention: BRYAN Cervical Disc Prosthesis
Number of subjects: 115

Group type: COMPARATOR
Intervention: ACDF (Control group)
Number of subjects: 115
Study: 16126016

Group type: EXPERIMENTAL
Intervention: Oral daily ibandronate (2.5 mg)
Number of subjects: 1964

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1964
Study: 11874442

Group type: EXPERIMENTAL
Intervention: 10 mg sibutramine bid
Number of subjects: 150

Group type: COMPARATOR
Intervention: 120 mg orlistat tid
Number of subjects: 150

Group type: COMPARATOR
Intervention: 850 mg metformin bid
Number of subjects: 150
Study: 10440605

Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg or 10 mg)
Number of subjects: 567

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 567
Study: 7560246

Group type: EXPERIMENTAL
Intervention: MS-CRS (controlled-release suppository)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Subcutaneous morphine
Number of subjects: 10
Study: 2185342

Group type: EXPERIMENTAL
Intervention: Concomitant chemoradiotherapy
Number of subjects: 0
Study: 6938013

Group type: EXPERIMENTAL
Intervention: 5 mg diethylstilbestrol (DES) daily by mouth
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus radical prostatectomy
Number of subjects: 0
Study: 31134731

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT-T) delivered by trainee psychologists
Number of subjects: 52

Group type: COMPARATOR
Intervention: Waitlist control (4-week wait period)
Number of subjects: 52
Study: 28880609

Group type: EXPERIMENTAL
Intervention: Discontinued use of antipsychotics
Number of subjects: 67

Group type: COMPARATOR
Intervention: Continued use of antipsychotics
Number of subjects: 67
Study: 25478740

Group type: EXPERIMENTAL
Intervention: Computer-aided diagnosis (CAD) tool for classification of pulmonary nodules
Number of subjects: 150

Group type: COMPARATOR
Intervention: Human expert classification
Number of subjects: 150
Study: 24065920

Group type: EXPERIMENTAL
Intervention: Nicotine patch
Number of subjects: 77
Study: 21720181

Group type: COMPARATOR
Intervention: Probiotics
Number of subjects: 1223
Study: 19249182

Group type: EXPERIMENTAL
Intervention: 500 mg infused over 1 h every 8 h for complicated intra-abdominal infections
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1000 mg infused over 4 h every 8 h for hospital-acquired pneumonia
Number of subjects: 0
Study: 16199079

Group type: EXPERIMENTAL
Intervention: Cisplatin-paclitaxel
Number of subjects: 686

Group type: COMPARATOR
Intervention: Carboplatin-paclitaxel
Number of subjects: 686
Study: 12957743

Group type: EXPERIMENTAL
Intervention: Metronidazole 750 mg daily in divided doses for 14 days
Number of subjects: 30
Study: 11244516

Group type: EXPERIMENTAL
Intervention: Directional coronary atherectomy (DCA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Percutaneous transluminal coronary angioplasty (PTCA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atherectomy before Multilink Stent
Number of subjects: 0
Study: 10168581

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 8447035

Group type: EXPERIMENTAL
Intervention: Sucralfate powder
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 3722689

Group type: EXPERIMENTAL
Intervention: Different plastics for rigid contact lenses worn for four hours
Number of subjects: 0
Study: 29313486

Group type: EXPERIMENTAL
Intervention: Ivermectin (0.15 mg/kg)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 27680871

Group type: EXPERIMENTAL
Intervention: Self-observation (live video feedback of their own TPT performance)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Model observation (prerecorded video showing standard TPT)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (performed the TPT with no conditioning)
Number of subjects: 48
Study: 24354686

Group type: EXPERIMENTAL
Intervention: Clip attachments (group I, GI)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Silicone resilient liners (group II, GII)
Number of subjects: 30
Study: 22305412

Group type: EXPERIMENTAL
Intervention: Waterless scrub
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional scrub
Number of subjects: 100
Study: 21197713

Group type: EXPERIMENTAL
Intervention: Valganciclovir (900 mg) once daily for up to 200 days
Number of subjects: 318

Group type: COMPARATOR
Intervention: Valganciclovir (900 mg) once daily for up to 100 days
Number of subjects: 318
Study: 18438718

Group type: EXPERIMENTAL
Intervention: ACEI/ARB continuation group
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: ACEI/ARB discontinuation group
Number of subjects: 220

Group type: COMPARATOR
Intervention: Angiotensin blockade naïve group
Number of subjects: 220
Study: 14982549

Group type: EXPERIMENTAL
Intervention: Substance abuse treatment
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Higher doses of antiretroviral medication
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Use of drugs or alcohol in the previous 30 days
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: More depressive symptoms
Number of subjects: 349
Study: 11314834

Group type: EXPERIMENTAL
Intervention: Tramadol 1 mg/kg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Pethidine 0.5 mg/kg
Number of subjects: 30
Study: 9388088

Group type: EXPERIMENTAL
Intervention: High-fat meal (3766 J [900 calories], 50 g of fat)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Low-fat meal (3766 J [900 calories], 0 g of fat)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High-fat meal with vitamins C (1 g) and E (800 IU)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Low-fat meal with vitamins C (1 g) and E (800 IU)
Number of subjects: 20
Study: 8201642

Group type: EXPERIMENTAL
Intervention: Combined phenobarbital plus ergotamine
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Diethylstilbestrol
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Megestrol acetate
Number of subjects: 68
Study: 3147423

Group type: EXPERIMENTAL
Intervention: EMLA cream (local anaesthetic)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26

Group type: COMPARATOR
Intervention: Lignocaine injections
Number of subjects: 26
Study: 28038497

Group type: EXPERIMENTAL
Intervention: Picture book distraction intervention
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Animated cartoon distraction intervention
Number of subjects: 276

Group type: COMPARATOR
Intervention: Routine oral instructions (Control)
Number of subjects: 276
Study: 26705931

Group type: EXPERIMENTAL
Intervention: High-Dose Trivalent Inactivated Influenza Vaccine (60 μg HA/strain/dose)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Standard-Dose Trivalent Inactivated Influenza Vaccine (15 μg HA/strain/dose)
Number of subjects: 44
Study: 27337802

Group type: EXPERIMENTAL
Intervention: PCUM (critical care ultrasonic examination)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Conventional group
Number of subjects: 187
Study: 23357349

Group type: EXPERIMENTAL
Intervention: Preoperative PFMT (3 weeks before surgery and continued after surgery)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Postoperative PFMT (started after catheter removal)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Preoperative PFMT
Number of subjects: 180

Group type: COMPARATOR
Intervention: Postoperative PFMT
Number of subjects: 180
Study: 19515542

Group type: EXPERIMENTAL
Intervention: Dipeptidyl Peptidase‐4 (DPP‐4) inhibitors
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: DPP‐4 inhibitors
Number of subjects: 41
Study: 18437480

Group type: EXPERIMENTAL
Intervention: Indigenous balloon dissection (group 1)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Direct telescopic dissection (group 2)
Number of subjects: 56
Study: 17161067

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents
Number of subjects: 126

Group type: COMPARATOR
Intervention: Bare-metal stents
Number of subjects: 126
Study: 12707819

Group type: EXPERIMENTAL
Intervention: Laparoscopic hernioplasty
Number of subjects: 27

Group type: COMPARATOR
Intervention: Conventional repair
Number of subjects: 27
Study: 10645918

Group type: EXPERIMENTAL
Intervention: Abciximab plus reduced-dose tPA (combination therapy)
Number of subjects: 346

Group type: COMPARATOR
Intervention: tPA alone (control)
Number of subjects: 346
Study: 8785148

Group type: EXPERIMENTAL
Intervention: Vecuronium 0.05 mg kg‐1
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Laryngoscopy (after vecuronium and saline)
Number of subjects: 40
Study: 1558994

Group type: EXPERIMENTAL
Intervention: Topical alpha-interferon ointment with dimethyl sulfoxide
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 4052837

Group type: EXPERIMENTAL
Intervention: Sexual abuse prevention training program (3-hour duration)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 0
Study: 31187955

Group type: EXPERIMENTAL
Intervention: Nitrox 99
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nitrox 50
Number of subjects: 10

Group type: COMPARATOR
Intervention: Air
Number of subjects: 10
Study: 28864073

Group type: EXPERIMENTAL
Intervention: Intensity-modulated radiotherapy (IMRT) planned using pre-induction chemotherapy images (group A)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Intensity-modulated radiotherapy (IMRT) planned using post-induction chemotherapy images (group B)
Number of subjects: 212
Study: 26967222

Group type: EXPERIMENTAL
Intervention: SR 23 mg/day donepezil
Number of subjects: 351

Group type: COMPARATOR
Intervention: IR 10 mg/day donepezil
Number of subjects: 351
Study: 24895339

Group type: EXPERIMENTAL
Intervention: RA-CHOP
Number of subjects: 787

Group type: COMPARATOR
Intervention: R-CHOP
Number of subjects: 787
Study: 22849758

Group type: EXPERIMENTAL
Intervention: Progesterone (300 mg at h.s. daily)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Progesterone (during withdrawal study)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo (during withdrawal study)
Number of subjects: 46
Study: 20833266

Group type: EXPERIMENTAL
Intervention: CRT with a defibrillator (CRT-D)
Number of subjects: 1803

Group type: COMPARATOR
Intervention: Defibrillator-only therapy
Number of subjects: 1803
Study: 16815571

Group type: EXPERIMENTAL
Intervention: Exercise training program (ETP) consisting of 24 training sessions with aerobic exercise and muscle strengthening
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Exercise training program (ETP)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (2-month control period)
Number of subjects: 30
Study: 15179643

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (Dysport) injections (200U each into medial and lateral heads of gastrocnemius and 400U each into tibialis posterior) and Functional Electric Stimulation (FES) used daily for 16 weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (physiotherapy at the same rate)
Number of subjects: 21
Study: 11453318

Group type: EXPERIMENTAL
Intervention: Almitrine (50 mg bid)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (20 mg tid)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Almitrine (50 mg bid) and Medroxyprogesterone acetate (20 mg tid)
Number of subjects: 48
Study: 9870483

Group type: EXPERIMENTAL
Intervention: Bicarbonate solution (38 mmol/l of bicarbonate)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Bicarbonate/lactate solution (25 mmol/l bicarbonate and 15 mmol/l lactate)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control solution (40 mmol/l lactate)
Number of subjects: 59
Study: 7809441

Group type: EXPERIMENTAL
Intervention: Flutter VRP1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active cycle of breathing techniques
Number of subjects: 0
Study: 2972785

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Naloxone (100 micrograms/kg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Beta-endorphin (in vitro before exercise)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Beta-endorphin (after exercise)
Number of subjects: 8
Study: 29278818

Group type: EXPERIMENTAL
Intervention: Ondansetron 8 mg three times daily
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 27235677

Group type: EXPERIMENTAL
Intervention: 20‐mL 1% buffered lidocaine four‐site PCB with a 3‐min wait prior to cervical dilation
Number of subjects: 332

Group type: COMPARATOR
Intervention: 20‐mL 1% buffered lidocaine four‐site PCB with no wait prior to cervical dilation
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: 20‐mL 1% buffered lidocaine four‐site PCB (four‐site)
Number of subjects: 332

Group type: COMPARATOR
Intervention: 20‐mL 1% buffered lidocaine two‐site PCB
Number of subjects: 332
Study: 25626066

Group type: EXPERIMENTAL
Intervention: Patent blue dye (BD) combined with preoperative lymphoscintigraphy (LSG) and gamma probe (GP)
Number of subjects: 1088

Group type: COMPARATOR
Intervention: Patent blue dye (BD) alone
Number of subjects: 1088
Study: 23289648

Group type: EXPERIMENTAL
Intervention: 3 month pedometer and accelerometer based intervention supported by practice nurse physical activity consultations.
Number of subjects: 300
Study: 20537805

Group type: EXPERIMENTAL
Intervention: Cold Pressor Test (CPT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 0
Study: 18356335

Group type: EXPERIMENTAL
Intervention: Sodium iron EDTA (NaFeEDTA) at 10 mg/kg flour
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Ferrous fumarate at 20 mg/kg flour
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Electrolytic iron at 35 mg/kg flour
Number of subjects: 361

Group type: COMPARATOR
Intervention: No fortification iron (Control)
Number of subjects: 361
Study: 17046465

Group type: EXPERIMENTAL
Intervention: Sunitinib
Number of subjects: 312

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 312
Study: 14725229

Group type: EXPERIMENTAL
Intervention: Milligan‐Morgan haemorrhoidectomy plus chemical sphincterotomy (Group A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Milligan‐Morgan haemorrhoidectomy plus internal left lateral sphincterotomy (0.8‐1 cm) (Group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Milligan‐Morgan haemorrhoidectomy alone (Group C)
Number of subjects: 60
Study: 15794071

Group type: EXPERIMENTAL
Intervention: Pseudoephedrine (60 mg)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 238
Study: 10510524

Group type: EXPERIMENTAL
Intervention: Glove method
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Handwash method
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Wipe method
Number of subjects: 8
Study: 7614644

Group type: EXPERIMENTAL
Intervention: Granisetron (20 micrograms.kg‐1)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Granisetron plus Dexamethasone (20 micrograms.kg‐1 and 8 mg)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 88
Study: 2037957

Group type: EXPERIMENTAL
Intervention: Decalcified freeze-dried bone allograft (DFDBA) combined with an expanded polytetrafluoroethylene membrane (e-PTFE)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Barrier technique alone (e-PTFE membrane)
Number of subjects: 30
Study: 7211827

Group type: EXPERIMENTAL
Intervention: Handwashing program (HWC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control centers (CC)
Number of subjects: 0
Study: 27792852

Group type: EXPERIMENTAL
Intervention: Cognitive rest and graduated return to usual activity discharge instructions
Number of subjects: 118

Group type: COMPARATOR
Intervention: Usual care discharge instructions (control group)
Number of subjects: 118
Study: 25026508

Group type: EXPERIMENTAL
Intervention: Breathing retraining plus manual therapy (MT), n=30
Number of subjects: 60

Group type: COMPARATOR
Intervention: Breathing retraining (standard treatment), n=30
Number of subjects: 60
Study: 23625093

Group type: EXPERIMENTAL
Intervention: Cryoballoon ablation of the pulmonary veins (CAPV)
Number of subjects: 63
Study: 22060249

Group type: EXPERIMENTAL
Intervention: Mindfulness training
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Distraction training
Number of subjects: 57

Group type: COMPARATOR
Intervention: No training (control group)
Number of subjects: 57
Study: 19088467

Group type: EXPERIMENTAL
Intervention: Subcutaneous epoetin
Number of subjects: 157

Group type: COMPARATOR
Intervention: Intravenous epoetin
Number of subjects: 157
Study: 17570848

Group type: EXPERIMENTAL
Intervention: Artesunate plus amodiaquine (Arsucam)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Artesunate plus mefloquine (Artequin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Artemether plus lumefantrine (Coartem; four doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Artemether plus lumefantrine (Coartem; six doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amodiaquine plus sulphadoxine‐pyrimethamine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All combinations
Number of subjects: 0
Study: 15126812

Group type: EXPERIMENTAL
Intervention: Alfuzosin 10 mg once daily
Number of subjects: 360

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 360
Study: 11820045

Group type: EXPERIMENTAL
Intervention: 10% carbamide peroxide gel with 3% potassium nitrate and 0.11 fluoride ion
Number of subjects: 21

Group type: COMPARATOR
Intervention: 10% carbamide peroxide gel only (control)
Number of subjects: 21
Study: 9924466

Group type: EXPERIMENTAL
Intervention: 150 IU oral nHuIFN-alpha/day
Number of subjects: 559

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 559
Study: 7816333

Group type: EXPERIMENTAL
Intervention: Melatonin (5 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 3041248

Group type: EXPERIMENTAL
Intervention: Hormone treatment (oestrogen and norethisterone acetate)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 31142348

Group type: EXPERIMENTAL
Intervention: Mailed fecal test and stepped phone-outreach intervention program (Hybrid 1)
Number of subjects: 57673

Group type: EXPERIMENTAL
Intervention: Mailed fecal immunochemical test (FIT) outreach (Hybrid 2)
Number of subjects: 57673

Group type: EXPERIMENTAL
Intervention: Two strategies for implementing mailed FIT programs (Hybrid 3)
Number of subjects: 57673
Study: 28327566

Group type: EXPERIMENTAL
Intervention: Wholegrain rye (WGR)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Refined wheat (RW)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Wholegrain wheat (WGW)
Number of subjects: 70
Study: 26275453

Group type: EXPERIMENTAL
Intervention: Plumpy'doz
Number of subjects: 5536

Group type: EXPERIMENTAL
Intervention: Rice-lentil based food
Number of subjects: 5536

Group type: EXPERIMENTAL
Intervention: Chickpea based food
Number of subjects: 5536

Group type: EXPERIMENTAL
Intervention: Fortified blended food (WSB++)
Number of subjects: 5536

Group type: COMPARATOR
Intervention: Nutrition counselling alone
Number of subjects: 5536
Study: 23652778

Group type: EXPERIMENTAL
Intervention: Furosemide (20 mg intravenous injection)
Number of subjects: 859

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 859
Study: 21829522

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (tDCS) over the left dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cathodal transcranial direct current stimulation (tDCS) over the left dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 0
Study: 19074543

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 33
Study: 17627814

Group type: EXPERIMENTAL
Intervention: Oral DHEA (50mg capsules, 2 capsules daily for 14 days)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Percutaneous DHEA (4g of 10% DHEA cream or gel daily for 14 days)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 36
Study: 15303137

Group type: EXPERIMENTAL
Intervention: Intraoperative autotransfusion (IAT) using ZITI‐3000 Cell saving system
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no intraoperative autotransfusion)
Number of subjects: 20
Study: 11748599

Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitization and Reprocessing (EMDR) treatment
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 32
Study: 9449495

Group type: EXPERIMENTAL
Intervention: Aerosol beclomethasone dipropionate spray (84 microg four times per day)
Number of subjects: 747

Group type: COMPARATOR
Intervention: Sustained-release theophylline (doses adjusted for optimum control, twice per day)
Number of subjects: 747
Study: 7875922

Group type: EXPERIMENTAL
Intervention: Carleton Skills Training Program (CSTP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Modified training program (without physical enactment instructions)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both training programs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CSTP
Number of subjects: 0

Group type: COMPARATOR
Intervention: Modified training program
Number of subjects: 0
Study: 2212369

Group type: EXPERIMENTAL
Intervention: single pathway monophasic pulsing
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: single pathway biphasic pulsing
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: dual pathway sequential pulsing
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: dual pathway simultaneous pulsing
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: best pulsing technique for each patient
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: transvenous defibrillation techniques
Number of subjects: 12

Group type: COMPARATOR
Intervention: one transvenous defibrillation method
Number of subjects: 12
Study: 105777

Group type: EXPERIMENTAL
Intervention: Elemental diet (ED group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional treatment (control group)
Number of subjects: 30